Advanced Filters
noise

mitral-valve-regurgitation Clinical Trials

A listing of mitral-valve-regurgitation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 220 clinical trials
A Alessandro Galluzzo, MD

The FOCUS-ADHF Registry

Acute heart failure (AHF) represents a significant clinical and economic burden due to its impact on patients' quality of life, poor prognosis, and high healthcare costs. Despite advancements in treatment, the optimal therapeutic management of these patients, particularly those with severely reduced ejection fraction and dilated left ventricles, remains uncertain. …

years of age All Phase N/A
D Dr Shonit Punwani

Development of Novel MR Techniques Using Volunteer Participants

Using magnetic resonance (MR) imaging or spectroscopy as part of clinical research typically involves developing new MR protocols. Although some of this work is done by scanning artificial 'phantoms', volunteer studies are normally needed to configure and validate new protocols appropriately. Developing new MR protocols and techniques is also useful …

18 years of age All Phase N/A

Serotonin Receptor Blockers in Ischemic Mitral Regurgitation

This study is intended to investigate the effect of cyproheptadine (a 5HT2B receptor blocker) on mitral regurgitation severity.

18 - 80 years of age All Phase 2
A Aakriti Gupta, M.D.

Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation

The goal of this observational study is to compare the outcomes of transcatheter edge-to-edge repair (TEER) versus surgical mitral valve repair for degenerative mitral regurgitation (DMR) over the long term. The study aims to: Evaluate the effectiveness and safety of TEER versus surgery in patients with DMR over long term. …

60 years of age All Phase N/A
J Jonathan Beaudoin, MD

Effects of VALsartan On atRIAl Mitral Regurgitation (VALORIA) - Pilot

The goal of this clinical trial is to learn whether valsartan can slow the progression of atrial functional mitral regurgitation (AFMR) in adults with preserved left ventricular ejection fraction. The study will also evaluate the safety and tolerability of valsartan in this population. The main questions it aims to answer …

18 - 85 years of age All Phase 2/3
J Jian'an Wang, MD

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment.

18 years of age All Phase N/A

MRS Measurement of Glutamate and GABA Metabolism in Brain

This study will use magnetic resonance spectroscopy (MRS) to measure in the brain the transfer of \[13\]C as it is naturally metabolized from glucose to specific chemical transmitters. From this method, we can measure the rate of production of an important excitatory neurotransmitter (glutamate) as well as an inhibitory neurotransmitter …

18 - 65 years of age All Phase N/A

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

21 years of age All Phase N/A

MR Guidance for Liver and Pancreas

This is a single centre, single arm, prospective feasibility study that aims to see whether magnetic resonance imaging (MRI) as a source of image guidance before each radiation treatment fraction is feasible, and also if it may provide information that could potentially be used during the treatment to improve the …

18 years of age All Phase N/A
M Marisa Sanchez

Physiologic MR Imaging of Salivary Gland Tumors

The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.

18 years of age All Phase N/A

Simplify language using AI